Public, NASDAQ:ACHN
NASDAQ Global Market
Achillion Pharmaceuticals, Inc. - SWOT Analysis - http://www.companiesandmarkets.com adds new report
Date: Thu, 27 Nov 2008 01:33:01 GMT
Tags:
Achillion Pharmaceuticals, Inc. - SWOT Analysis - http://www.companiesandmarkets.com adds new report
Live-PR.com (Pressemitteilung) - Nov 27, 2008
Live-PR.com (Pressemitteilung) - Nov 27, 2008
Achillion Pharmaceuticals, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company´s key business structure and ...
ACHN: To Present At Lazard Capital Healthcare Conference @ 13:40 ET [delayed]
Date: Tue, 18 Nov 2008 17:34:48 GMT
Tags:
ACHN: To Present At Lazard Capital Healthcare Conference @ 13:40 ET [delayed]
Trading Markets (press release) - Nov 18, 2008
Trading Markets (press release) - Nov 18, 2008
Ridgeland, MS, NOV 18, 2008 (EventX/Knobias.com via COMTEX) -- ACHN | Quote | Chart | News | PowerRating -- Company representatives of Achillion Pharmaceuticals, Incorporated (NasdaqNM: ACHN ...
Achillion to Present At Lazard Capital Markets 5th Annual Healthcare Conference
Date: Mon, 17 Nov 2008 12:11:09 GMT
Tags:
Achillion to Present At Lazard Capital Markets 5th Annual Healthcare Conference
CNNMoney.com (press release) - Nov 17, 2008
CNNMoney.com (press release) - Nov 17, 2008
NEW HAVEN, Conn., Nov. 17, 2008 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN), a leader in the discovery and development of small molecule drugs to combat the most challenging ...
Achillion Pharmaceuticals Inc - SWOT Analysis - New Research Report on Companies and Markets
Date: Sat, 15 Nov 2008 18:46:53 GMT
Tags:
Achillion Pharmaceuticals Inc - SWOT Analysis - New Research Report on Companies and Markets
Live-PR.com (Pressemitteilung) - Nov 15, 2008
Live-PR.com (Pressemitteilung) - Nov 15, 2008
Achillion Pharmaceuticals Inc Company Profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history ...
Premium Company Profile - Achillion Pharmaceuticals - New Research Report on Companies and Markets
Date: Fri, 14 Nov 2008 21:17:09 GMT
Tags:
Premium Company Profile - Achillion Pharmaceuticals - New Research Report on Companies and Markets
Live-PR.com (Pressemitteilung) - Nov 14, 2008
Live-PR.com (Pressemitteilung) - Nov 14, 2008
Achillion is developing treatments for HIV infection, chronic hepatitis C infection and serious hospital-based bacterial infections. The company has advanced its lead drug candidate, Elvucitabine ...
Achillion Pharma: Hepatitis Drug Dev Pipeline Now Fully Funded (at Seeking Alpha)
Date: Tue, 25 Nov 2008 08:16:46 Etc/GMT
Tags:
Achillion to Present At Lazard Capital Markets 5th Annual Healthcare Conference (GlobeNewswire)
Date: Mon, 17 Nov 2008 12:00:00 Etc/GMT
Tags:
ACHILLION PHARMACEUTICALS INC Financials (EDGAR Online Financials)
Date: Sat, 1 Nov 2008 13:04:09 Etc/GMT
Tags:
Zacks #1 Rank Additions for Thursday (Zacks.com)
Date: Thu, 30 Oct 2008 12:42:19 Etc/GMT
Tags:
Here are the stocks added to the Zacks #1 Rank List for Thursday.
Achillion Pharma downgraded by Oppenheimer (Briefing.com)
Date: Thu, 30 Oct 2008 10:55:25 Etc/GMT
Tags: